Tumours were stratified by LKB1 loss in two biomarker studies examining LKB1 expression in NSCLC and head and neck squamous cell carcinoma (Kline et al, 2011; Nakada et al, 2013). Here, STK11 is linked to non-small cell lung carcinoma.